Rock Springs Capital Management LP Galera Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

  • $3.22 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$1.27 - $8.28 $721,680 - $4.71 Million
-568,252 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$8.35 - $12.39 $5,845 - $8,673
700 Added 0.12%
568,252 $5.01 Million
Q2 2020

Aug 14, 2020
BUY
$7.14 - $14.41 $482,321 - $973,424
67,552 Added 13.51%
567,552 $4.05 Million
Q4 2019

Feb 14, 2020
BUY
$9.13 - $13.9 $4.57 Million - $6.95 Million
500,000 New
500,000 $6.58 Million

Others Institutions Holding GRTX

# of Institutions
3
Shares Held
961K
Call Options Held
0
Put Options Held
0
View Full List

About Galera Therapeutics, Inc.

GRTX Quotes by TradingView
  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $1.34M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email